How the interaction occurs:
Leucovorin and high-doses of folic acid enhance the effects of fluorouracil, including the side effects.
What might happen:
You may experience more severe and/or prolonged side effects, such as diarrhea, and mouth inflammation/sores.
What you should do about this interaction:
Let your healthcare professionals (e.g. doctor or pharmacist) know that you are taking these medicines together.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
1.Midgley R, Kerr DJ. Capecitabine: have we got the dose right?. Nat Clin Pract Oncol 2009 Jan;6(1):17-24.
2.Bayraktar S, Gluck S. Management of capecitabine-related gastrointestinal toxicities in women with breast cancer. Commun Oncol 2011 Feb;8:81-87.
3.Leucovorin calcium US prescribing information. Bedford Laboratories September, 2008.
4.Clippe C, Freyer G, Milano G, Trillet-Lenoir V. Lethal toxicity of capecitabine due to abusive folic acid prescription?. Clin Oncol (R Coll Radiol) 2003 Aug;15(5):299-300.
5.Mainwaring P, Grygiel JJ. Interaction of 5-fluorouracil with folates. Aust N Z J Med 1995 Feb;25(1):60.
6.Jansman FG, Jansen AJ, Coenen JL, de Graaf JC, Smit WM, Sleijfer DT, Brouwers JR. Assessing the clinical significance of drug interactions with fluorouracil in patients with colorectal cancer. Am J Health Syst Pharm 2005 Sep 1;62(17):1788-93.
7.Figoli F, Chiarion Sileni V, Gulisano M, Maggian P, Fosser V. Leucovorin calcium enhancement of mucositis after continuous infusion fluorouracil and short infusion cisplatin. J Clin Oncol 1989 May;7(5):680-1.
8.Grem JL, Shoemaker DD, Petrelli NJ, Douglass HO Jr. Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma. Cancer Treat Rep 1987 Nov; 71(11):1122.
9.Stein TA, Burns GP, Bailey B, Citron ML. 5-Fluorouracil pharmacokinetics in patients with metastatic colorectal carcinoma after high-dose leucovorin. Cancer Invest 1994;12(4):375-8.